Senores Pharmaceuticals schedules 9th AGM for September 25, 2026
- Senores Pharmaceuticals schedules its 9th AGM for September 25, 2026
- The meeting will be held via video conferencing at 11:30 am
- Remote e-voting opens on September 22 and closes on September 24
- The cut-off date for voting eligibility is September 18, 2026
- Annual Report for FY26 is available electronically to registered members
*this image is generated using AI for illustrative purposes only.
Senores Pharmaceuticals has scheduled its ninth annual general meeting for Friday, September 25, 2026. The event will be conducted through video conferencing or other audio-visual means.
The company disclosed the schedule pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The notice also includes the Annual Report and Business Responsibility and Sustainability Report for FY26.
Meeting Details
The AGM is set to begin at 11:30 am. Shareholders can participate remotely via the specified digital platforms. The company will send the Annual Report electronically to members with registered email addresses.
E-Voting Schedule
Remote e-voting will commence three days before the meeting. Members must hold shares as of the cut-off date to be eligible for voting rights.
| Event | Date and Time |
|---|---|
| Cut-off date for e-voting eligibility | Friday, September 18, 2026 |
| Remote e-voting start | Tuesday, September 22, 2026, 9:00 am |
| Remote e-voting end | Thursday, September 24, 2026, 5:00 pm |
| AGM date and time | Friday, September 25, 2026, 11:30 am |
Members whose email addresses are not registered with the company or depository participants have received separate communication with a web link to access the Annual Report on the company's website.
Historical Stock Returns for Senores Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.32% | -4.30% | +9.55% | +86.74% | +105.37% | 0.0% |
What key financial performance metrics or strategic initiatives are expected to be highlighted in Senores Pharmaceuticals' FY26 Annual Report?
How might the company's Business Responsibility and Sustainability Report influence investor sentiment regarding ESG compliance and long-term viability?
Are there any proposed changes to the board of directors or executive compensation packages that shareholders will vote on during the AGM?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
